Abstract:Peste des petits ruminants (PPR) is one of the most contagious and fatal diseases of small ruminants in the world and is classified as a category A epidemic disease. It is the target of a global eradication campaign led by the Office International des Epizooties (OIE) and Food and Agriculture Organization of the United Nations (FAO). The PPR live attenuated vaccine is currently the most widely used and approved vaccine, but the use of this vaccine interferes with the serological testing of the PPR elimination program, and there is a potential safety risk. Viral vector vaccines are one of the most promising methods to solve this dilemma. In this study, the full-length infectious clone plasmid of rabies virus (RABV), pD-SRV9-PM-LASV, was used as the backbone, and the envelope glycoprotein H (hemagglutinin protein) or F (fusion protein) gene of PPRV was inserted into the backbone plasmid to construct the infectious clones pD-SRV9-PM-PPRV-H and pD-SRV9-PM-PPRV-F, which express the PPRV H and PPRV F genes, respectively. The correct construction of these infectious clones was verified after sequencing and double digestion. The infectious clones were transfected with a helper plasmid into BSR/T7 cells, and recombinant viruses were successfully rescued by direct immunofluorescence, indirect immunofluorescence, Western blotting, and transmission electron microscopy and named rSRV9-H and rSRV9-F. The results of growth kinetics studies indicated that the inserted gene did not affect virus proliferation. Stability studies revealed that the inserted target gene was stably expressed in recombinant RABV for at least 15 generations. In this study, the recombinant viruses rSRV9-H and rSRV9-F were successfully rescued. The constructed viruses had good proliferative activity and stability and provided potential bivalent inactivated vaccine candidate strains for the prevention of PPR and livestock rabies.

Construction of Replicate Defective Recombinant Adenovirus Expressing Glycoprotein of Rabies Virus

Cell Surface Display of Rabies Virus Glycoprotein by Using Ice Nucleation Protein

Construction of the Recombinant Adenovirus Expressing Gc Glycoprotein Gene for Developing Vaccine Against Pseudorabies Virus

Cloning and Expression of the Nucleoprotein Gene of Era Rabies Virus

Novel Strategy for Expression and Characterization of Rabies Virus Glycoprotein

Construction and Identification of Recombinant Adenovirus Vector Expressing LacZ Gene

Expression of Recombinant Rabies Virus Glycoprotein in Saccharomyces Cerevisiae

Prokaryotic Expression,Purification and Identification of Rabies Virus Glycoprotein Extracellular Domain Gene

High Level Expression of Rabies Virus Glycoprotein Extracellular Domain Gene in Escherichia Coli

[Construction and Expression of Recombinant Adenovirus Expression Vector of Beta-Defensin-2].

Construction and Identification of Recombinant Adenovirus Expression VP1 of Foot and Mouth Disease Virus

Design and generation of recombinant rabies virus vectors

Construction of Recombinant Rabies Virus Vectors Expressing H or F Protein of Peste des Petits Ruminants Virus

Prokaryoticexpression and Immunoreactivity Analysis of Rabies G Protein

EXPRESSION AND CHARACTERIZATION OF PHOSPHOPROTEIN OF RABIES VIRUS IN BACULOVIRUS

A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs

Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice

Construction and Characterization of Recombinant Adenovirus with Porcine Reproductive and Respiratory Syndrome Virus GP5

Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells

Construction and Identification of Recombinant Adenovirus Coexpression PRRSV GP5 Gene and Porcine Interferon-γ Gene

Construction of Eukaryotic Expression Vector for Fusion Gene RV-G/LTB and Its Expression in Vero Cells